"fwiw, i think ponatinib holds a great deal of promise and upside for the company. just not so sure how much more legroom the company stock has in the next six months considering where it came from and its current market cap."
Pardon me BTH, but didn't you make that very same calculation with Exel?
Btw, it's the Aria board, what do you two expect? Not the place if you are looking for a meaningful debate.
News 
Market Data 
Discover 
